Maria Cristina Pirosa

6PUBLICATIONS
55CO-AUTHORS
Rheumatology and arthritisOther European languagesWomen's studies (incl. girls' studies)Haematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.

|Jun 22, 2025
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG).

Annarita Conconi, Andrea Janikova, Barbara Vannata

|Sep 26, 2024
Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35).

Maria Cristina Pirosa, Sara Steffanoni, Anna Vanazzi

|Feb 01, 2024
Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma.

Maria Cristina Pirosa, Anastasios Stathis, Emanuele Zucca

|Oct 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphoma.

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti

|Sep 09, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab.

Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina

Pageof 1

Frequent Collaborators

5 joint publications

Emanuele Zucca

2 joint publications

Martin R Faderl

2 joint publications

Bernhard Gerber

2 joint publications

Maria Elena Cabrera